IMMUNIC INC's ticker is IMUX and the CUSIP is 4525EP101. A total of 56 filers reported holding IMMUNIC INC in Q3 2023. The put-call ratio across all filers is 15.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $467,045 | -55.1% | 317,718 | -23.3% | 0.00% | -66.7% |
| Q2 2023 | $1,039,185 | +74.2% | 414,018 | +3.4% | 0.00% | +50.0% |
| Q1 2023 | $596,474 | -24.8% | 400,318 | -29.3% | 0.00% | 0.0% |
| Q4 2022 | $792,985 | +70.5% | 566,418 | +284.7% | 0.00% | +100.0% |
| Q3 2022 | $465,000 | -7.2% | 147,218 | +1.9% | 0.00% | 0.0% |
| Q2 2022 | $501,000 | -66.3% | 144,518 | +9.7% | 0.00% | -75.0% |
| Q1 2022 | $1,488,000 | +0.1% | 131,718 | -15.2% | 0.00% | 0.0% |
| Q4 2021 | $1,487,000 | +1.7% | 155,418 | -5.9% | 0.00% | 0.0% |
| Q3 2021 | $1,462,000 | -26.5% | 165,218 | +1.8% | 0.00% | -20.0% |
| Q2 2021 | $1,990,000 | -35.3% | 162,318 | -15.9% | 0.01% | -37.5% |
| Q1 2021 | $3,075,000 | -0.2% | 192,918 | -4.2% | 0.01% | 0.0% |
| Q4 2020 | $3,080,000 | +39.4% | 201,418 | +69.2% | 0.01% | +33.3% |
| Q3 2020 | $2,210,000 | – | 119,018 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 1,788,160 | $2,628,595 | 2.41% |
| Gratus Capital, LLC | 1,686,455 | $2,479,089 | 0.17% |
| INNOVIS ASSET MANAGEMENT LLC | 272,457 | $400,512 | 0.15% |
| Parkman Healthcare Partners LLC | 562,506 | $826,884 | 0.15% |
| RTW INVESTMENTS, LP | 4,335,255 | $6,372,825 | 0.13% |
| Logos Global Management LP | 421,184 | $619,140 | 0.08% |
| Ikarian Capital, LLC | 450,000 | $661,501 | 0.08% |
| BVF INC/IL | 1,149,425 | $1,689,655 | 0.05% |
| Soleus Capital Management, L.P. | 300,000 | $441,000 | 0.04% |
| COWEN AND COMPANY, LLC | 317,059 | $466,076 | 0.03% |